| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |